HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PLD1
phospholipase D1
Chromosome 3 Β· 3q26.31
NCBI Gene: 5337Ensembl: ENSG00000075651.18HGNC: HGNC:9067UniProt: Q13393
210PubMed Papers
21Diseases
0Drugs
28Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Trending
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
regulation of synaptic vesicle cycleapical plasma membraneendocytic vesiclecholinergic synapsecardiac valvular defect, developmentalsmoking initiationPLD1-related congenital heart diseasegenetic disorder
✦AI Summary

PLD1 (phospholipase D1) functions as a phospholipase that selectively hydrolyzes phosphatidylcholine to produce phosphatidic acid and choline 1. The enzyme contains two highly conserved HKD motifs essential for catalysis and dimerization, and is regulated by protein kinase C and small GTPases of the Rho and ARF families 1. PLD1 plays critical roles in multiple cellular processes including signal transduction, membrane trafficking, and mitosis regulation. In oocyte meiosis, PLD1 promotes spindle assembly and migration by maintaining levels of ACTR2, PtdIns(4,5)P2, and phosphorylated cofilin through modulation of autophagy flux 2. The enzyme negatively regulates autophagosome formation, with its depletion leading to increased autophagosome formation and upregulated phosphatidic acid content 3. In cancer contexts, PLD1 contributes to chemoresistance through non-enzymatic interactions with NPM1, promoting nuclear translocation and transcriptional upregulation of IL7R, which activates JAK1/STAT5/BCL-2 signaling pathways 4. PLD1 has also been implicated in cancer stemness and drug resistance through cross-talk between PI3K/Akt and Wnt/Ξ²-catenin pathways 5. Additionally, exome sequencing studies have identified PLD1 associations with brain imaging phenotypes and neural development 6.

Sources cited
1
PLD1 hydrolyzes phosphatidylcholine to phosphatidic acid and choline, contains HKD motifs for catalysis, and is regulated by protein kinase C and GTPases
PMID: 10818442
2
PLD1 promotes spindle assembly and migration in oocyte meiosis by maintaining ACTR2, PtdIns(4,5)P2, and phosphorylated cofilin levels through autophagy modulation
PMID: 38513669
3
PLD1 negatively regulates autophagosome formation and its depletion increases cellular phosphatidic acid content
PMID: 28318354
4
PLD1 confers gemcitabine resistance through non-enzymatic interaction with NPM1 and activation of JAK1/STAT5/BCL-2 signaling
PMID: 37381714
5
PLD1 contributes to cancer stemness and chemoresistance through cross-talk between PI3K/Akt and Wnt/Ξ²-catenin pathways
PMID: 38945955
6
PLD1 is associated with brain imaging phenotypes and neural development
PMID: 34662886
Disease Associationsβ“˜21
cardiac valvular defect, developmentalOpen Targets
0.70Moderate
smoking initiationOpen Targets
0.41Moderate
PLD1-related congenital heart diseaseOpen Targets
0.37Weak
genetic disorderOpen Targets
0.34Weak
placenta praeviaOpen Targets
0.30Weak
viral eye infectionOpen Targets
0.30Weak
brain cancerOpen Targets
0.26Weak
Abruptio PlacentaeOpen Targets
0.26Weak
cataractOpen Targets
0.24Weak
trauma complicationOpen Targets
0.24Weak
cardiomyopathyOpen Targets
0.19Weak
congenital heart malformationOpen Targets
0.19Weak
Alzheimer diseaseOpen Targets
0.10Suggestive
neoplasmOpen Targets
0.09Suggestive
glioblastoma multiformeOpen Targets
0.09Suggestive
osteosarcomaOpen Targets
0.09Suggestive
cancerOpen Targets
0.08Suggestive
gliomaOpen Targets
0.08Suggestive
colorectal carcinomaOpen Targets
0.08Suggestive
autosomal dominant macrothrombocytopeniaOpen Targets
0.08Suggestive
Cardiac valvular dysplasia 1UniProt
Pathogenic Variants28
NM_002662.5(PLD1):c.1219C>T (p.Arg407Ter)Pathogenic
Cardiac valvular defect, developmental
β˜…β˜…β˜†β˜†2025β†’ Residue 407
NM_002662.5(PLD1):c.2034del (p.Trp678fs)Pathogenic
Cardiac valvular defect, developmental|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 678
NM_002662.5(PLD1):c.2681A>C (p.Tyr894Ser)Likely pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 894
NM_002662.5(PLD1):c.2430-1G>APathogenic
not provided|Malignant tumor of esophagus
β˜…β˜…β˜†β˜†2024
NM_002662.5(PLD1):c.665+1G>APathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_002662.5(PLD1):c.2178del (p.Ala727fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 727
NM_002662.5(PLD1):c.1745del (p.Ser582fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 582
NM_002662.5(PLD1):c.892C>T (p.Arg298Ter)Pathogenic
Cardiac valvular defect, developmental
β˜…β˜†β˜†β˜†2025β†’ Residue 298
NM_002662.5(PLD1):c.2338G>A (p.Glu780Lys)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 780
NM_002662.5(PLD1):c.904_905del (p.Leu302fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 302
NM_002662.5(PLD1):c.2914G>T (p.Glu972Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 972
NM_002662.5(PLD1):c.472C>T (p.Arg158Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 158
NM_002662.5(PLD1):c.1403T>A (p.Val468Asp)Likely pathogenic
Cardiac valvular defect, developmental
β˜…β˜†β˜†β˜†2023β†’ Residue 468
NM_002662.5(PLD1):c.1061+1G>ALikely pathogenic
Cardiac valvular defect, developmental
β˜…β˜†β˜†β˜†2023
NM_002662.5(PLD1):c.2602C>T (p.Gln868Ter)Likely pathogenic
Cardiac valvular defect, developmental
β˜…β˜†β˜†β˜†2022β†’ Residue 868
NM_002662.5(PLD1):c.2416del (p.Ile805_Leu806insTer)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 805
NM_002662.5(PLD1):c.1708del (p.His570fs)Likely pathogenic
Cardiac valvular defect, developmental
β˜…β˜†β˜†β˜†2022β†’ Residue 570
NM_002662.5(PLD1):c.607-2A>CPathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_002662.5(PLD1):c.1276_1279del (p.Ala426fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2021β†’ Residue 426
NM_002662.5(PLD1):c.1484_1485del (p.Thr495fs)Likely pathogenic
Cardiac valvular defect, developmental|not provided
β˜…β˜†β˜†β˜†2021β†’ Residue 495
View on ClinVar β†—
Related Genes
PISDProtein interaction98%PEMTProtein interaction97%LPCAT2Protein interaction96%LPCAT3Protein interaction96%LPCAT1Protein interaction96%PLPP2Protein interaction96%
Tissue Expression6 tissues
Heart
100%
Bone Marrow
95%
Ovary
76%
Liver
53%
Brain
34%
Lung
16%
Gene Interaction Network
Click a node to explore
PLD1PISDPEMTLPCAT2LPCAT3LPCAT1PLPP2
PROTEIN STRUCTURE
Preparing viewer…
PDB6U8Z Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.82LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.61 [0.46–0.82]
RankingsWhere PLD1 stands among ~20K protein-coding genes
  • #1,989of 20,598
    Most Researched210 Β· top 10%
  • #1,864of 5,498
    Most Pathogenic Variants28
  • #6,967of 17,882
    Most Constrained (LOEUF)0.82
Genes detectedPLD1
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
Exome sequencing and analysis of 454,787 UK Biobank participants.
PMID: 34662886
Nature Β· 2021
1.00
2
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
PMID: 36750721
Signal Transduct Target Ther Β· 2023
0.90
3
PLD1 promotes spindle assembly and migration through regulating autophagy in mouse oocyte meiosis.
PMID: 38513669
Autophagy Β· 2024
0.80
4
Crystal structure of human PLD1 provides insight into activation by PI(4,5)P
PMID: 32198492
Nat Chem Biol Β· 2020
0.76
5
Phospholipase D.
PMID: 10818442
Ann N Y Acad Sci Β· 2000
0.70